Aberrant promoter hypermethylation of CHFR in nasopharyngeal carcinoma.
- Author:
Tingting HUANG
1
;
Chunping DU
;
Nana YU
;
Xue XIAO
;
Xiaoying ZHOU
;
Shurnin WANG
;
Guangwu HUANG
;
Zhe ZHANG
Author Information
1. Department of Otolaryngology Head and Neck Surgery, the First Affiliated Hospital, Guangxi Medical University, Nanning, 530021, China.
- Publication Type:Journal Article
- MeSH:
Aged;
Carcinoma;
Cell Cycle Proteins;
genetics;
DNA Methylation;
Epigenesis, Genetic;
Female;
Gene Silencing;
Humans;
Male;
Middle Aged;
Nasopharyngeal Carcinoma;
Nasopharyngeal Neoplasms;
genetics;
pathology;
Neoplasm Proteins;
genetics;
Neoplasm Staging;
Poly-ADP-Ribose Binding Proteins;
Promoter Regions, Genetic;
Ubiquitin-Protein Ligases
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2011;25(16):746-750
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To discover the relationship of transcriptional levels and promoter methylation status of CHFR gene in human nasopharyngeal carcinoma,to discuss the significance and epigenetic mechanism of CHFR inactivation in NPC, and to evaluate the feasibility of detecting methylated CHFR in nasopharyngeal swab as a means for diagnosis of NPC.
METHOD:Transcriptional levels of CHFR was evaluated by RT-PCR. Methylation specific PCR was used to detect the methylation status of CHFR in NPC cells, normal nasopharyngeal epithelia, primary tumors and their paired nasopharyngeal swabs. Detailed methylation status was confirmed by bisulfite sequencing. NPC cells were treated by the methyltransferase inhibitor 5-aza-dC and the reactivation of CHFR was evaluated by RT-PCR.
RESULT:CHFR transcription was inactivated in NPC. The methylation frequency in NPC primary tumors and their paired swabs were 65.5% and 63.8%, respectively, with a 86.2% concordance. Bisulfite sequencing revealed a dense methylation in NPC cells and primary tumors, but all the normal nasopharyngeal epithelia were unmethylated. CHFR expression were restored after 5-aza-dC treatment.
CONCLUSION:CHFR is epigenetically inactivated by promoter methylation in NPC. Detecting methylated CHFR can be served as a useful non-invasive means for diagnosis of NPC.
